You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 27, 2026

List of Excipients in API febuxostat tablets 40 mg

✉ Email this page to a colleague

« Back to Dashboard

Excipients in ANDA-approved (generic) drugs containing febuxostat tablets 40 mg

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC	Excipient
Macleods Pharmaceuticals Limited	febuxostat tablets 40 mg	33342-274	CELLULOSE, MICROCRYSTALLINE
Macleods Pharmaceuticals Limited	febuxostat tablets 40 mg	33342-274	CROSCARMELLOSE SODIUM
Macleods Pharmaceuticals Limited	febuxostat tablets 40 mg	33342-274	FD&C BLUE NO. 1
Macleods Pharmaceuticals Limited	febuxostat tablets 40 mg	33342-274	FD&C RED NO. 40
Macleods Pharmaceuticals Limited	febuxostat tablets 40 mg	33342-274	FD&C YELLOW NO. 5
Macleods Pharmaceuticals Limited	febuxostat tablets 40 mg	33342-274	HYDROXYPROPYL CELLULOSE
Macleods Pharmaceuticals Limited	febuxostat tablets 40 mg	33342-274	LACTOSE MONOHYDRATE
>Company	>Ingredient	>NDC	>Excipient

Detailed excipient profiles for febuxostat tablets 40 mg

Excipient focus: CELLULOSE, MICROCRYSTALLINE

febuxostat tablets 40 mg drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Macleods Pharmaceuticals Limited	febuxostat tablets 40 mg	33342-274
>Company	>Ingredient	>NDC

febuxostat tablets 40 mg drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: CROSCARMELLOSE SODIUM

febuxostat tablets 40 mg drug variants containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Macleods Pharmaceuticals Limited	febuxostat tablets 40 mg	33342-274
>Company	>Ingredient	>NDC

febuxostat tablets 40 mg drug variants not containing CROSCARMELLOSE SODIUM

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FD&C BLUE NO. 1

febuxostat tablets 40 mg drug variants containing FD&C BLUE NO. 1

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Macleods Pharmaceuticals Limited	febuxostat tablets 40 mg	33342-274
>Company	>Ingredient	>NDC

febuxostat tablets 40 mg drug variants not containing FD&C BLUE NO. 1

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FD&C RED NO. 40

febuxostat tablets 40 mg drug variants containing FD&C RED NO. 40

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Macleods Pharmaceuticals Limited	febuxostat tablets 40 mg	33342-274
>Company	>Ingredient	>NDC

febuxostat tablets 40 mg drug variants not containing FD&C RED NO. 40

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: FD&C YELLOW NO. 5

febuxostat tablets 40 mg drug variants containing FD&C YELLOW NO. 5

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Macleods Pharmaceuticals Limited	febuxostat tablets 40 mg	33342-274
>Company	>Ingredient	>NDC

febuxostat tablets 40 mg drug variants not containing FD&C YELLOW NO. 5

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HYDROXYPROPYL CELLULOSE

febuxostat tablets 40 mg drug variants containing HYDROXYPROPYL CELLULOSE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Macleods Pharmaceuticals Limited	febuxostat tablets 40 mg	33342-274
>Company	>Ingredient	>NDC

febuxostat tablets 40 mg drug variants not containing HYDROXYPROPYL CELLULOSE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: LACTOSE MONOHYDRATE

febuxostat tablets 40 mg drug variants containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Macleods Pharmaceuticals Limited	febuxostat tablets 40 mg	33342-274
>Company	>Ingredient	>NDC

febuxostat tablets 40 mg drug variants not containing LACTOSE MONOHYDRATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

febuxostat tablets 40 mg drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Macleods Pharmaceuticals Limited	febuxostat tablets 40 mg	33342-274
>Company	>Ingredient	>NDC

febuxostat tablets 40 mg drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYVINYL ALCOHOL

febuxostat tablets 40 mg drug variants containing POLYVINYL ALCOHOL

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Macleods Pharmaceuticals Limited	febuxostat tablets 40 mg	33342-274
>Company	>Ingredient	>NDC

febuxostat tablets 40 mg drug variants not containing POLYVINYL ALCOHOL

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SILICON DIOXIDE

febuxostat tablets 40 mg drug variants containing SILICON DIOXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Macleods Pharmaceuticals Limited	febuxostat tablets 40 mg	33342-274
>Company	>Ingredient	>NDC

febuxostat tablets 40 mg drug variants not containing SILICON DIOXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TALC

febuxostat tablets 40 mg drug variants containing TALC

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Macleods Pharmaceuticals Limited	febuxostat tablets 40 mg	33342-274
>Company	>Ingredient	>NDC

febuxostat tablets 40 mg drug variants not containing TALC

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

febuxostat tablets 40 mg drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
Macleods Pharmaceuticals Limited	febuxostat tablets 40 mg	33342-274
>Company	>Ingredient	>NDC

febuxostat tablets 40 mg drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.